Artiva Biotherapeutics, Common Stock Price on November 14, 2024
| ARTV Stock | 10.40 0.22 2.07% |
If you're considering investing in Artiva Stock, it is important to understand the factors that can impact its price. As of today, the current price of Artiva Biotherapeutics, stands at 10.40, as last reported on the 18th of December 2024, with the highest price reaching 10.91 and the lowest price hitting 10.13 during the day. At this stage we consider Artiva Stock to be slightly risky. Artiva Biotherapeutics, secures Sharpe Ratio (or Efficiency) of 0.003, which signifies that the company had a 0.003% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Artiva Biotherapeutics, Common, which you can use to evaluate the volatility of the firm. Please confirm Artiva Biotherapeutics,'s Downside Deviation of 6.24, mean deviation of 5.03, and Risk Adjusted Performance of 0.0395 to double-check if the risk estimate we provide is consistent with the expected return of 0.0197%.
At this time, Artiva Biotherapeutics,'s Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 120.3 M in 2024, whereas Total Stockholder Equity is likely to drop (170.1 M) in 2024. . Price Earnings To Growth Ratio is likely to climb to 0.39 in 2024, whereas Price To Sales Ratio is likely to drop 3.18 in 2024. Artiva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Artiva |
Sharpe Ratio = 0.003
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARTV |
Estimated Market Risk
| 6.59 actual daily | 58 58% of assets are less volatile |
Expected Return
| 0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Artiva Biotherapeutics, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Artiva Biotherapeutics, by adding Artiva Biotherapeutics, to a well-diversified portfolio.
Price Book 1.2568 | Price Sales 97.1198 | Shares Float 4 M | Wall Street Target Price 21.25 | Earnings Share (2.48) |
Artiva Biotherapeutics, Main Headline on 14th of November 2024
Artiva Biotherapeutics Given Buy Rating at Needham Company L... by thelincolnianonline.com
Needham Company LLC reaffirmed their buy rating on shares of Artiva Biotherapeutics in a report published on Wednesday,Benzinga reports. Needham Company LLC currently has a 23.00 price target on the stock. A number of other research firms have also recently weighed in on ARTV. Wedbush reaffirmed an outperform rating
Artiva Biotherapeutics, Valuation on November 14, 2024
It is possible to determine the worth of Artiva Biotherapeutics, on a given historical date. On November 14, 2024 Artiva was worth 11.95 at the beginning of the trading date compared to the closed value of 10.51. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Artiva Biotherapeutics, stock. Still, in general, we apply an absolute valuation method to find Artiva Biotherapeutics,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Artiva Biotherapeutics, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Artiva Biotherapeutics,'s related companies.
| Open | High | Low | Close | Volume | |
| 13.26 | 13.85 | 11.70 | 11.70 | 32,200 | |
11/14/2024 | 11.95 | 12.17 | 10.50 | 10.51 | 48,487 |
| 10.93 | 10.93 | 10.05 | 10.06 | 97,320 |
| Backtest Artiva Biotherapeutics, | | | Artiva Biotherapeutics, History | | | Artiva Biotherapeutics, Valuation | Previous | Next |
Artiva Biotherapeutics, Trading Date Momentum on November 14, 2024
| On November 15 2024 Artiva Biotherapeutics, Common was traded for 10.06 at the closing time. The top price for the day was 10.93 and the lowest listed price was 10.05 . The trading volume for the day was 97.3 K. The trading history from November 15, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.28% . The overall trading delta against the current closing price is 9.51% . |
Artiva Biotherapeutics, Fundamentals Correlations and Trends
By evaluating Artiva Biotherapeutics,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Artiva Biotherapeutics,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Artiva financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Artiva Biotherapeutics, Stock history
Artiva Biotherapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Artiva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Artiva Biotherapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Artiva Biotherapeutics, stock prices may prove useful in developing a viable investing in Artiva Biotherapeutics,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 9.4 M | 12.4 M |
Artiva Biotherapeutics, Quarterly Net Working Capital |
|
Artiva Biotherapeutics, Stock Technical Analysis
Artiva Biotherapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Artiva Biotherapeutics, Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
Artiva Biotherapeutics, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Artiva Biotherapeutics, December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Artiva Biotherapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Artiva Biotherapeutics, shares will generate the highest return on investment. By undertsting and applying Artiva Biotherapeutics, stock market strength indicators, traders can identify Artiva Biotherapeutics, Common entry and exit signals to maximize returns
Artiva Biotherapeutics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Artiva Biotherapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Artiva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Artiva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0395 | |||
| Jensen Alpha | 0.1963 | |||
| Total Risk Alpha | (0.26) | |||
| Sortino Ratio | 0.0344 | |||
| Treynor Ratio | 0.2073 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Artiva Stock Analysis
When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.